Avanza Fonder Ab Merck & Co., Inc. Transaction History
Avanza Fonder Ab
- $3.86 Trillion
- Q3 2025
A detailed history of Avanza Fonder Ab transactions in Merck & Co., Inc. stock. As of the latest transaction made, Avanza Fonder Ab holds 264,376 shares of MRK stock, worth $24.5 Million. This represents 0.58% of its overall portfolio holdings.
Number of Shares
264,376
Previous 244,553
8.11%
Holding current value
$24.5 Million
Previous $19.4 Billion
14.62%
% of portfolio
0.58%
Previous 0.57%
Shares
4 transactions
Others Institutions Holding MRK
# of Institutions
3,880Shares Held
1.9BCall Options Held
31.1MPut Options Held
28.5M-
Vanguard Group Inc Valley Forge, PA252MShares$23.4 Billion0.33% of portfolio
-
Black Rock Inc. New York, NY207MShares$19.2 Billion0.59% of portfolio
-
State Street Corp Boston, MA118MShares$11 Billion0.35% of portfolio
-
Wellington Management Group LLP Boston, MA75.3MShares$6.99 Billion1.16% of portfolio
-
Geode Capital Management, LLC Boston, MA59.8MShares$5.55 Billion0.33% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $235B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...